OLGA and OLGIM Stage System for Gastric Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Atrophic Gastritis
- Intestinal Metaplasia
- Stomach Neoplasms
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 25 years and 80 years
- Gender
- Both males and females
Description
To validated the OLGA and OLGIM staging system with serum pepsinogen to estimate gastric cancer risk according to Lauren's histologic classification in South Korea, where the incidence rate of GC is high. In addition, the investigators attempted to investigate the interaction among the several risk ...
To validated the OLGA and OLGIM staging system with serum pepsinogen to estimate gastric cancer risk according to Lauren's histologic classification in South Korea, where the incidence rate of GC is high. In addition, the investigators attempted to investigate the interaction among the several risk factors including OLGA or OLGIM staging system for the risk of GC to help establish surveillance strategy.
Tracking Information
- NCT #
- NCT03380052
- Collaborators
- National Clinical Research Coordination Center, Seoul, Korea
- Investigators
- Principal Investigator: Officials Officials, Officials Seoul National University Bundang Hospital
Get Well Soon